Amir Tahami

Amir Tahami
Contact Information
Address: 

100 Tice Blvd, Woodcliff Lake, NJ 07677, USA

Phone: 
514-333-4203
Email address: 
amir.tahami [at] mcgill.ca
Biography: 

Amir Tahami has been leading diverse global and local activities dedicated to defining, developing, and delivering scientific evidence of clinical and economic value to ensure patients, payers, and providers have the best possible information for healthcare decision-making and health policy about innovative medicines. During his career, he has developed, launched, and commercialized over twenty medicines in various therapeutic areas, including respiratory, cardiovascular, diabetes, infectious diseases (HIV and HCV), immunology, oncology, and neurology including the industry-leading medicines in immuno-oncology—YERVOY® and OPDIVO®—and the blockbusters—NASONEX®, REMICADE®, SIMPONI®, and ELIQUIS®.

 

Areas of expertise: 

Research areas span a range of topics in Epidemiology and Biostatistics and are driven by an interest in developing statistically sound solutions to real-world problems, particularly in the design and application of Pharmacoepidemiology, Pharmacoeconomics, and Health Services Research.

Group: 
Adjunct Professors
Research areas: 
Epidemiologic Methods
Health Services and Health Policy
Pharmacoepidemiology
Areas of interest: 

Biostatistics, Clinical Epidemiology, Epidemiologic Methods, Health and Social Policy, Health Services Research, Health Technology Assessment, Pharmacoepidemiology, Pharmacoeconomics.

Back to top